Every new New York filing, every dayAlumis Inc. is a publicly traded biotechnology company developing targeted therapies for immune-mediated diseases. The website emphasizes a precision approach to replace broad immunosuppression, with a pipeline built through a merger with Acelyrin. Contact information includes a South San Francisco phone number and a New Jersey address, consistent with a biopharma firm.
Filed August 26, 2025 · Manhattan, NY
Your competitors in Manhattan are getting unlimited new business leads.

Every new New York filing, every day
See how it worksALUMIS INC. is a biotechnology business (Corp) registered on August 26, 2025 with the New York Division of Corporations. The business is located in Manhattan, New York 10005.
New verified leads every morning, and an AI-built email campaign ready to go. We build it, you hit send.
Build My Campaign Free ›We matched this business to its website and pulled the domain's registration (WHOIS) record. Domain age is one of the strongest signals that a filing is a truly new business and not a re-filing or paperwork change.
Filing timeline will be available soon.
ALUMIS INC. was registered as Corp on August 26, 2025 in New York.
ALUMIS INC. is based in Manhattan, NY, 10005.
ALUMIS INC. is classified as a biotechnology business (precision immunology).
No EIN was found on file for ALUMIS INC. at the time of registration.
Based on the business category, these service providers typically target this type of business.